President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in negotiations ahead of an Aug. 1 deadline for sweeping duties to take effect.

China's Ministry of State Security says it is cracking down on alleged smuggling of rare earths materials that it says ...

US President Donald Trump has threatened to impose a 200% tariff on pharmaceutical imports into the United States, and while ...

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

Multinationals are attracted to Chinese biotech companies' cost efficiencies, accelerated timelines and promising quality, ...

Tariff policies are changing so rapidly that it can be hard to keep up. Here are all of President Donald Trump's proposed, ...

Since US President Donald Trump – just days into his second term – began imposing tariffs on China for its role in the flow ...

The US and China recently reached a 90-day trade truce in Switzerland, but significant uncertainty remains about its long-term impact on global trade dynamics. Patrick Leblond, a professor at the ...

NEW DELHI – India has now been placed on the same level as China in supplying precursor chemicals used by drug cartels to manufacture fentanyl, according to the 2025 Annual Threat Assessment ...

Trump floats 200% tariff on medicines, while threat of 50% levy on copper imports sent price of metal to record high ...

China is “knee deep” in fueling the fentanyl crisis in the U.S., even offering tax rebates for illicit drugs to capitalize on the chaos and devastation, congressional leaders charge.

China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See the complete analysis here.